Download MendeleyFunctional and Structural Insights into a Novel Promiscuous Ketoreductase of the Lugdunomycin Biosynthetic Pathway.
Xiao, X., Elsayed, S.S., Wu, C., van der Heul, H.U., Metsa-Ketela, M., Du, C., Prota, A.E., Chen, C.C., Liu, W., Guo, R.T., Abrahams, J.P., van Wezel, G.P.(2020) ACS Chem Biol 15: 2529-2538
- PubMed: 32840360
- DOI: https://doi.org/10.1021/acschembio.0c00564
- Primary Citation of Related Structures:
6YPZ, 6YQ0, 6YQ3, 6YQ6 - PubMed Abstract:
Angucyclines are a structurally diverse class of actinobacterial natural products defined by their varied polycyclic ring systems, which display a wide range of biological activities. We recently discovered lugdunomycin ( 1 ), a highly rearranged polyketide antibiotic derived from the angucycline backbone that is synthesized via several yet unexplained enzymatic reactions. Here, we show via in vivo , in vitro , and structural analysis that the promiscuous reductase LugOII catalyzes both a C6 and an unprecedented C1 ketoreduction. This then sets the stage for the subsequent C-ring cleavage that is key to the rearranged scaffolds of 1 . The 1.1 Å structures of LugOII in complex with either ligand 8- O -Methylrabelomycin ( 4 ) or 8- O -Methyltetrangomycin ( 5 ) and of apoenzyme were resolved, which revealed a canonical Rossman fold and a remarkable conformational change during substrate capture and release. Mutational analysis uncovered key residues for substrate access, position, and catalysis as well as specific determinants that control its dual functionality. The insights obtained in this work hold promise for the discovery and engineering of other promiscuous reductases that may be harnessed for the generation of novel biocatalysts for chemoenzymatic applications.
Organizational Affiliation:
Molecular Biotechnology, Leiden University, PO Box 9505, 2300RA Leiden, The Netherlands.
